Biogen (BIIB) soars following a positive Alzheimer’s drug trial. George Tsilis discusses this, as BMO Capital, Baird, and Mizuho analysts upgraded BIIB. He also talks about the hurdles that BIIB is having to face including how they are closer to regulatory approval but do not have it yet. He then demonstrates an example trade using BIIB. The trade type is a put vertical and the direction is neutral to bullish. Tune in to find out more about the stock market today.
Trading 360
28 Sep 2022
SHARE
Next Gen Investing
05 Jul 2023
Trading 360
10 Jul 2023
Market On Close
07 Jul 2023
Morning Trade Live
15 Sep 2023
Morning Trade Live
08 Aug 2023
Trading 360
29 Jun 2023